Javier is a healthcare professional with more than 20 years of experience, 11 of which were spent working for two major pharmaceutical companies, mainly in the areas of pharmacoepidemiology and drug safety. He worked as a senior epidemiologist, medical advisor and study medical expert, with global responsibilities in the areas of neuroscience (neurology and psychiatry), anti-inflammatories, hematology and solid tumor oncology.
Javier has contributed to several therapeutic risk management plans and has interacted with health authorities internationally, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Agence française de sécurité sanitaire des produits de santé (AFSSAPS). He has experience in the planning, implementation and analysis of several drug and disease registries and databases, as well as in the development and implementation of signal detection for pharmacovigilance. He has a particular interest in gerontology and comparative effectiveness research. His work has been presented at professional scientific conferences and published in numerous leading industry journals, including The Journal of the American Medical Association (JAMA), Medicina Clinica (Barc), The Journal of the American Dietetic Association, The American Journal of Clinical Nutrition, Public Health and Revista Española de Salud Pública.
Javier received his MD from the University of Zaragoza Medical School in Zaragoza, Spain; his MPH from the National School of Public Health in Madrid; his DrPH from Johns Hopkins University School of Hygiene and Public Health in Baltimore; his corporate MBA from the ESADE Business School in Barcelona; and his MSc in health economics and pharmacoeconomics from the Universitat Pompeu Fabra in Barcelona. He is also a certified specialist in preventive medicine and public health.